IMCS growing into new space, adding positions see more
An Irmo-based biotechnology company is investing $4.1 million to expand its Richland County operations in a move expected to create 31 jobs during the next five years.
Integrated Micro-Chromatography Systems Inc. creates, manufactures and distributes products and services for clients including clinical and forensic toxicology labs, academic research facilities, federal government agencies and health science companies. In January, the National Institutes of Health awarded the company a $900,000 Small Business Innovation Research Fast-Track grant.
“Over the past several years, IMCS has experienced considerable success as a part of the Richland County business community,” Andrew Lee, IMCS CEO, said in a news release. “The tax incentives provided by the county will allow us to continue investing in people, capital equipment and facilities to expand our company and increase economic development in the county.”
Richland County Council approved a special source revenue credit to reduce property taxes for IMCS by 35% over a 10-year period.
“County Council is always eager to support growing businesses in Richland County, and it is especially exciting to watch a company like IMCS get its start here and achieve so much,” Paul Livingston, county council chair, said. “The investment and new jobs IMCS is bringing to our community will benefit our residents and are evidence of the type of success businesses can achieve here.”
IMCS’ enzymes are used in drug-testing labs, and drug discovery labs use the company’s micro separations products to discover antibodies that can be used to fight diseases such as COVID-19. IMCS is using the federal grant to scale up production of new enzymes that will be used to make therapeutic drugs for treating neurodegenerative diseases such as Parkinson’s and Alzheimer’s.
The grant is funding research into the production of affordable gangliosides, biomolecules that contain sugars and a type of lipid called ceramides and play critical roles in various biological processes.
In addition to its headquarters in Richland County, IMCS bought a second nearby facility in 2019 and anticipates purchasing a larger building in the county in the future, according to the release from Richland County. IMCS is combining the existing facilities to ramp up production and delivery of its products to pharmaceutical companies worldwide.
“We were a USC IdeaLabs incubator company and have continued to grow in the county over the past seven years,” Lee said. “As we look to expand our operation to a third facility, it is only natural that we would want to do so here.”
The new investment and jobs will be split between IMCS’ Irmo headquarters and the new facility.
Founded in 2013 by three Ph.D. scientists from the University of South Carolina, IMCS now has 40 full-time employees, with 600 clients in every U.S. state and in 15 countries.
Prisma Health, USC to collaborate on innovations see more
The University of South Carolina and Prisma Health – the state’s largest not-for-profit health organization – are announcing a partnership that aims to encourage the development and implementation of innovative health care delivery models, medical devices, digital health applications, and treatments for diseases.
Under the arrangement, which was approved by UofSC’s Board of Trustees on February 21, the University’s Office of Economic Engagement will assist Prisma Health – along with the UofSC Schools of Medicine in Columbia and Greenville – in identifying opportunities to develop mutually beneficial relationships with industry partners, bridging the gap between Prisma Health’s cutting-edge health research and the development of new technologies that help patients.
“At Prisma Health, we strive to go beyond treating diseases or their symptoms and aim to find cures and to design medical devices and digital capabilities that allow us to restore and transform lives,” said Mark O’Halla, President and Chief Executive Officer at Prisma Health. “Harnessing our expertise and that of the University of South Carolina together will help us accelerate our ability to address society’s most significant health challenges.“
Specifically, Prisma Health and UofSC will collaborate on a number of opportunities, including intellectual property patents and technology transfer support, operations development, cybersecurity, institutional insights, and strategic planning – all towards the shared goal of furthering research and innovation towards improving treatments and health care delivery. At its core, this partnership will drive innovation through UofSC’s extended successes delivering education, mentoring programs, and incubation asset development, as well as Prisma Health’s experience in leveraging its clinical and non-clinical expertise in the health care market, to drive innovations from benchside prototypes to clinical outcomes.
“This strengthens the outstanding partnership that already exists with Prisma Health. We are greatly committed to addressing the health needs of all South Carolina residents, and working together with Prisma in academics, research and patient care will make a real difference,” said UofSC President Bob Caslen.
As the state’s flagship university, UofSC is uniquely suited to help Prisma Health develop research or innovation partnerships that can lead to higher healthcare outcomes for patients across the state. This new relationship builds off of previous partnerships the university had with Prisma Health and its legacy predecessors, Greenville Health System and Palmetto Health, before they combined in 2019 to form Prisma Health.
“We have an extensive history of facilitating and supporting innovation efforts across multiple sectors,” said Bill Kirkland, executive director of UofSC’s Office of Economic Engagement. “Through this partnership with Prisma Health, we will now apply our commercialization and entrepreneurial successes to healthcare and life sciences. While this relationship will bear fruit for both insitutions, the real winners are the people of South Carolina, who stand to benefit from better access to care, innovative treatments, and the latest applications of research.”
“Prisma Health is committed to improving the health of South Carolinians,” said Brenda Thames, Prisma Health chief academic executive officer. “We are adapting to an ever-changing and increasingly challenging healthcare environment by becoming a learning health system that adopts rapid cycle innovation processes. While research provides the mechanism for evaluating and comparing the effectiveness of existing care models, innovation allows us to develop and improve new care models.”
Dr. David Cull, Prisma Health vice president of clinical and academic integration, added, “Through this partnership, we will create, test, and implement innovative initiatives that challenge the status quo and have the potential to reduce the cost of care, improve quality, and increase access to healthcare services.”
Chad Hardaway discusses The Office of Economic Engagement at the University of South Carolina and its newest programsChad Hardaway of USC discusses new programs in this interview. see more
The Office of Economic Engagement (OEE) was formed in 2013 at the University of South Carolina to better connect businesses with the resources of a top-tier research institution.
The OEE offers businesses one point of contact at the university. Four critical functions are now all housed under one roof: 1) technology commercialization, 2) the USC/Columbia Technology Incubator, 3) the Innovista Research campus, and 4) the Corporate Solutions Group.
Under this organizational structure, the Office of Economic Engagement builds academic and industry partnerships, facilitates the commercialization of research, connects new and existing businesses with university talent and resources, and fosters entrepreneurship and small business development.
This year, the University of South Carolina is starting a new graduate program, the MS in Technology Innovation and Entrepreneurial Engineering. It is the only graduate program in the State of South Carolina that places a high premium on students with an engineering and science background, blending their technical and business skills in an entrepreneurial way.